In Vivo briefly summarizes the technologies of these recently founded companies: Efficas Inc., Gloucester Pharmaceuticals Inc., Helicos BioSciences Corp., Home Dialysis Plus, Imagine Pharmaceuticals Inc. and ProteinLogic Ltd.
4730 Walnut Street, Suite 108
Boulder, CO 80301
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy
Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.
In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.
